### 13251 Federal Register / Vol. 80, No. 49 / Friday, March 13, 2015 / Rules and Regulations

**ENVIRONMENTAL PROTECTION AGENCY** 

**40 CFR Part 22**

**[EPA–HQ–OECA–2014–0551; FRL–9922– 62–OECA]** 

**Consolidated Rules of Practice Governing the Administrative**  **Assessment of Civil Penalties, Issuance of Compliance or Corrective**  **Action Orders, and the Revocation, Termination or Suspension of Permits;**  **Correction**

**AGENCY :**  Environmental Protection Agency.

**ACTION :**  Correcting amendment.

**SUMMARY :**  The Environmental Protection Agency (EPA) published a document in the Federal Register on November 6, 2014. That document included the correct mailing and hand delivery addresses for the Environmental Appeals Board, but inadvertently failed to omit the incorrect addresses. This amendment deletes the incorrect addresses.

**DATES :**  Effective on March 13, 2015.

**FOR FURTHER INFORMATION CONTACT :**  Ammie Roseman-Orr, Environmental Appeals Board, U.S. Environmental Protection Agency, William Jefferson Clinton Building East, Room 3332, 1200 Pennsylvania Ave. NW., Mail Code 1103M, Washington DC 20460, phone number (202) 233–0122 or by email at roseman-orr.ammie@epa.gov.

**SUPPLEMENTARY INFORMATION :**  Background

The rule amendment published on November 6, 2014 (79 FR 65897), corrected the mailing and hand delivery addresses for the Environmental Appeals Board in § 22.5(a) to reflect the Board’s relocation. The rule also revised § 22.30(a)(1) by adding a reference to the corrected addresses in § 22.5(a). This amendment, however, inadvertently did not omit the Board’s incorrect addresses in the second and third sentences of § 22.30(a)(1).

Need for Correction

As published on November 6, 2014 (79 FR 65897), the final regulation contains an error which may prove to be misleading and is in need of clarification. List of Subjects in 40 CFR Part 22

Environmental protection, Administrative practice and procedure, Air pollution control, Hazardous substances, Hazardous waste, Penalties, Pesticides and pests, Poison prevention, Water pollution control. Dated: February 19, 2015. Nanci E. Gelb, Acting Assistant Administrator, Office of Administration and Resources Management.

Accordingly, 40 CFR part 22 is corrected by making the following correcting amendment:

**PART 22—CONSOLIDATED RULES OF PRACTICE GOVERNING THE**  **ADMINISTRATIVE ASSESSMENT OF CIVIL PENALTIES AND THE**  **REVOCATION, TERMINATION OR SUSPENSION OF PERMITS** 

■ 1. The authority citation for part 22 continues to read as follows:

Authority: 7 U.S.C. 136(l); 15 U.S.C. 2615; 33 U.S.C. 1319, 1342, 1361, 1415 and 1418; 42 U.S.C. 300g–3(g), 6912, 6925, 6928, 6991e and 6992d; 42 U.S.C. 7413(d), 7524(c), 7545(d), 7547, 7601 and 7607(a), 9609, and
11045.

**§ 22.30 [Corrected]**

■ 2. In § 22.30, paragraph (a)(1) is amended by removing the second and third sentences.

[FR Doc. 2015–05438 Filed 3–12–15; 8:45 am]

**BILLING CODE 6560–50–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Medicare & Medicaid Services** 

**42 CFR Parts 405, 411, 413 and 414**

**[CMS–1614–CN]**

**RIN 0938–AS13**

**Medicare Program; Quality Incentive Program; Correction** 

**AGENCY :**  Centers for Medicare & Medicaid Services (CMS), HHS.

**ACTION :**  Final rule; correction.

**SUMMARY :**  This document corrects technical errors that appeared in the final rule published in the Federal Register on November 6, 2014 entitled ‘‘End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies.’’

**DATES :**  This correction is effective on March 13, 2015.

**FOR FURTHER INFORMATION CONTACT :**  Tamyra Garcia, (410) 786–0856.

**SUPPLEMENTARY INFORMATION :**  I. Background

In FR Doc. 2014–26182 of November 6, 2014 (79 FR 66120), there were technical and typographical errors that are identified and corrected in the Correction of Errors section below. The provisions in this correction document are effective as if they had been included in the document published on November 6, 2014. Accordingly, the corrections are effective March 13, 2015. II. Summary of Errors

On page 66184 of the preamble, we have determined that there were errors in the performance standard, achievement threshold, and benchmark values presented in the Numerical Values for the Performance Standardsfor the Payment Year (PY) 2017 EndStage Renal Disease (ESRD) Quality Incentive Program (QIP) Clinical Measures Using the Most Recently Available Data table for PY 2017 of the ESRD QIP (Table 23). Specifically, the numerical values published for the Standardized Readmission Ratio clinical measure were calculated using only 6 months of data from calendar year 2013 instead of the full 12 months, as specified under our finalized policy (79 FR 66183). Therefore, we are publishing this technical correction to ensure that these numerical standards align with the finalized policies for the PY 2017 ESRD QIP. III. Waiver of Proposed Rulemaking

We ordinarily publish a notice of proposed rulemaking in the Federal Register to provide a period for public comment before the provisions of a rule take effect in accordance with section 553(b) of the Administrative Procedure Act (APA) (5 U.S.C. 553(b)). However, we can waive this notice and comment procedure if the Secretary finds, for good cause, that the notice and comment process is impracticable, unnecessary, or contrary to the public interest, and incorporates a statement of the finding and the reasons; therefore, in the notice.

Since this rule correction is simply correcting technical and typographical errors in the preamble, but does not make substantive changes to the policies or payment methodologies that were adopted in the final rule, it is unnecessary to follow the notice and comment procedure in this instance. Therefore, we believe that we have good cause to forego notice and a period for
comment.

IV. Correction of Errors

In FR Doc. 2014–26182 of November 6, 2014 (79 FR 66120) make the following corrections:

1. On page 66184, in Table 23 ‘‘Numerical Values for the Performance Standards for the PY 2017 ESRD QIP Clinical Measures Using the Most